Manupac, Rodjane .
HRN: 25-94-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2024
METRONIDAZOLE 500MG (TAB)
09/27/2024
10/04/2024
ORAL
500mg
TID
S/P NSD W/ RMLE; UTI; Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes